Pharmaceuticals
- Updated
- Mergers & acquisitions
‘50 years of toil, 50 years of grind’: Chemist Warehouse is now a $32 billion giant
The mega-merger with pharmaceutical distributor Sigma Healthcare has minted billions for the pharmacy chain’s three founders and spawned more than 100 millionaires, with their stakes worth between $5 million and $25 million.
- Jessica Yun
Latest
A small team of Australian scientists won a rare drug approval – and upended the pharma system
Hundreds of thousands of doses of moxidectin – which treats a disease caused by a parasitic worm – are being given to patients, the result of an audacious strategy offering a new way to develop medicine for neglected populations.
- Liam Mannix
- Opinion
- Opinion
If Australia made more of its own medicines, we’d all feel better
Australia imports about 90 per cent of its medicine, and this makes us incredibly vulnerable to any supply disruption. But it doesn’t have to be this way.
- Jennifer Martin
Scientists slam brakes on research that could lead to the perfect bioweapon
Potentially catastrophic risks to life as we know it have prompted dozens of eminent scientists to hit the brakes on their research.
- Angus Dalton
- Exclusive
- Vaccination
‘We don’t have a Team Australia approach’: Vaccine facility rejects plea for help
A request by NSW to access a taxpayer-funded Moderna mRNA facility was knocked back, raising more questions about how much value Australia is getting from the facility.
- Liam Mannix and Paul Sakkal
Pharmaceutical giant sued over ‘ineffective’ cold and flu drugs
Sick customers who bought some cold and flu medications have been falsely assured their nasal congestion would be relieved, an Australian class action alleges.
- Neve Brissenden
Can Ozempic make America slim again? RFK Jr and Musk are at odds
Two people whispering in Trump’s ear have opposing views on how to fix one of his biggest challenges: the country’s obesity problem.
- Gina Kolata
- Analysis
- Drugs
Anger, frustration and revolt: Inside the final day of NSW’s drug summit
As the drug summit unfolded, it became dominated by the one topic the government wanted off the table: decriminalisation.
- Michael McGowan and Angus Thomson
Dodgy science in crosshairs as fraud audit censures Australia’s top research agency
The National Health and Medical Research Council has been criticised over its lax approach to scientific misconduct in an audit that lays the groundwork for changes in the way bad science is policed.
- Liam Mannix
This asthma drug is taken by millions. Now scientists have found it in the brain
The findings, presented at a conference in Texas last week, have raised pressure on Australian authorities to better warn patients about the risks of montelukast.
- Angus Thomson
Original URL: https://www.theage.com.au/topic/pharmaceuticals-hnn